Why the study?
Does PlateletMapping compared with VerifyNow better detect aspirin resistance correlated with urinary thromboxane in patients undergoing invasive cardiac procedures?
Does PlateletMapping compared with VerifyNow better detect aspirin resistance correlated with urinary thromboxane in patients undergoing invasive cardiac procedures?
PlateletMapping may be a more useful point-of-care assay than VerifyNow for identifying aspirin resistance and stratifying perioperative risk.
No takes yet. Share an insight, caveat, or question.
PlateletMapping may identify more aspirin-resistant patients than VerifyNow; hypothesis-generating for perioperative risk stratification.
Carroll et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: